ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 134 filers reported holding ANAPTYSBIO INC in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,166,000 | +10.5% | 44,975 | -8.2% | 0.01% | 0.0% |
| Q1 2021 | $1,055,000 | +151.2% | 48,971 | +150.5% | 0.01% | +100.0% |
| Q4 2020 | $420,000 | -55.6% | 19,550 | -69.5% | 0.00% | -50.0% |
| Q3 2020 | $945,000 | -58.7% | 64,037 | -37.5% | 0.01% | -69.2% |
| Q2 2020 | $2,290,000 | +13.7% | 102,522 | -28.1% | 0.03% | -55.2% |
| Q1 2020 | $2,014,000 | +121.6% | 142,517 | +154.8% | 0.06% | +222.2% |
| Q4 2019 | $909,000 | -22.8% | 55,928 | +66.1% | 0.02% | -10.0% |
| Q3 2019 | $1,178,000 | +124.0% | 33,671 | +544.5% | 0.02% | +81.8% |
| Q4 2017 | $526,000 | – | 5,224 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |